Our mission

Our mission is to harness the advances of science and learnings from nature to develop transformative therapies.

Serving patients is at the core of everything we do. Our dedicated team of experienced scientists, physicians and professionals are passionate about building a pipeline of disruptive and differentiated multi-specific antibody products tailored to the needs of the patient.

Patients first

NovalGen is a patient-focused immunology company with a growing pipeline of unprecedented immunology medicines that enhances patient safety whilst making a major impact in the treatment of autoimmune, oncological, and other immunological disorders.

People focus

At NovalGen, we recognise our people as our most valuable asset. With a dedicated, entrepreneurial team passionate about our mission, we collaboratively harness exceptional talent and inclusive integration to accelerate progress towards the treatment of a diverse range of challenging disorders with high unmet needs.

Driven by innovation

Innovation is at our core and is our passion. Our dedicated focus is on pioneering the next wave of immunotherapies, engineered to deliver unparalleled potency while prioritising safety above all else.

More in this section

Our history

Headquartered in London, UK, NovalGen was formed in 2019. The company is based on proprietary innovations from UCL, London UK.